Brief: PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
March 27 (Reuters) - PDS Biotechnology Corp PDSB.O: PDS BIOTECH REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES CLINICAL PROGRAMS UPDATE Source text: ID:nGNXbcNQfH Further company coverage: PDSB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing